Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I dont want to know the news...I wanna know the other shit you guys find out here...I know penny's are dirty and people get info before it's PR
He's not an astute investor or day trader so it's hard for me to recommend to him a penny stock
Lol I used to use IHub and I know it's a good source for penny stock info...any info would be appreciated on what's going on here
Not sure but he is being offered shares of this company or cash so he asked if I knew anything about the company
What is this company? Had someone call me who is an investor in some sort of local education company and said he got an offer of a buyout and had the opportunity to own shares in this company...
Lol this is insane...this stock was confused for LAZR Luminar Technologies which just went public today...better sell if youre in the green!!
Ok, but a failed Phase III is far different than a scam
Lol cause FDAclinicaltrials.gov participates in scams
Agreed, let's see how easily it moves up on the round of volume, but at least the dilution appears to be done
I agree...I meant to post that, I suspect there will be anticipation buying which should provide some pressure to the upside and at a minimum supports should hold..I think if sub .20s print there won't be many of them
.2066 first support and second should be .1820...the 20 day SMA has not been breached once but has been touched multiple times on the weekly over the last 12 weeks...
It's officially been listed since August 7th when it says first posted
I'm watching the order book on E Trade pro and there are all these large transactions occuring that don't register in the daily volume or move the price...anyone with any ideas? I'm somewhat familiar with dark pools but never witnessed it..not sure when and how their buys/sells actually impact the stock price or if they do at all...seems strange...a lot of transactions this afternoon for same share count and large orders
Solid volume to open the day
That's what's interesting here though...they are a Canadian Company on CSE which requires quarterly filings, audited financials at a minimum... maybe disclosure of material events as well similar to an 8-K...so everything you want to see you can go to the CSE website...they simply do not have US filings or disclosures but there's more info out there for this company than a typical pink sheet
Na I don't want to lose credibility before I've worked to create it lol
If there's a level of efficacy and they have to do another offering it'll be at much higher prices and fewer shares, less dilution....my guess is that's their goal...get the trials started, let's see if there's some promise and then they can make their next move
My questions and Mike Frank's replies to my questions within a half hour
Sent from my iPhone
> On Aug 13, 2020, at 4:36 PM, Aaron <mail@revivethera.com> wrote:
>
> ?Hi I've made an investment into your company on the US side of the border and am considering making additional investments in light of the FDA advancement of Bucillamine to Phase 3 trials
>
> 1. Are you planning to get filings current? There are no filings on pink sheets. Any plans to use visibility of Bucillamine if proven efficacy in trials to get off Pink Sheets in US? Yes
> 2. Any updates you can offer to the investment community on how you plan to fund PH 3 ? We have close to 6 mill with warrant money so more than enough to start and can access more later through other sources
> 3. Are there any obstacles you foresee that could delay the start of the PH 3?
>
As discussed in press releases announced
Thanks
> Thank you and congratulations on your progress and good luck in the future
I understand, they've got a few irons in the fire... obviously the biggest catalyst being Covid
Revive made an update to this Ph 3 study on Tuesday...I cannot discern what the update was, anyone?
https://www.clinicaltrials.gov/ct2/show/NCT03660059?term=Bucillamine&draw=2&rank=6
The next news release will move this much more easily...it'll be announcement of first person with COVID to start taking Bucillamine and we should see .50+ ...any PRs even on the slightest bit of efficacy and of to multi dollars
Most likely right on the dilution, buy with all the volume the past 2 weeks it should be done and they should have enough cash to move forward with PH 3
Been in an uptrend since March...currently the trend line is around .185 and will go everyday...all is fine, especially on low volume drops with potentially big catalysts around the corner...just buy and or hold cause this will see .50 again very soon
I think the bottom is in, maybe 20 area, but expect people will start buying in anticipation of news before the August 30th trial date
this post presumes no drug should enter FDA trials to stop covid because since theres no true winner yet, they'll all be failures.
updated the study dates today
Estimated Study Start Date : August 30, 2020
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : May 1, 2021
Pretty sure those are the shares related to the warrants...need to look at the fully diluted share count at this point to determine market cap...still less than $75 million
K even though I don't understand the chemistry I think am convinced there's certainly a good probability of some positive reporting to be expected
Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine), which has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years, is a cysteine derivative with 2 thiol groups that is 16-fold more potent than NAC as a thiol donor in vivo, giving it vastly superior function in restoring glutathione and therefore greater potential to prevent acute lung injury during influenza infection.8 Bucillamine has also been shown to prevent oxidative and reperfusion injury in heart and liver tissues8 and is highly cell permeable for efficient delivery into cells.8,9 Bucillamine has unrealized potential for the treatment of influenza with both proven safety and proven mechanism of action similar to that of NAC, but with much higher potency, mitigating the previous obstacles to using thiols therapeutically. It is also reasonable to hypothesize that similar processes related to ROS are involved in acute lung injury during nCov-19 infection, possibly justifying the investigation of bucillamine as an intervention for COVID-19.
Will do...thank you!
I've read your past posts...you've provided tremendous insight into what now appears as a glaringly obvious massive opportunity...Based on your extensive knowledge of Bucillamine, what do you believe the likelihood the drug will show in having some efficacy in reaching it's primary endpoints? It seems to me the probability is better than most since the PH 3 came so easy and at the guidance of the FDA?
I'm simply trying to gauge risk/reward with the size of the investment...I already have $40k in at .23...thinking of adding more over the next couple weeks, but don't want to be in too deep on something I am not an expert in
Appreciate your insight, it's invaluable
I see it is stickied and you're a mod...lol nice post
Damn...awesome post
Mods sticky this shit at the TOP
This will be an interesting few months for sure, but CYDY has shown efficacy in treating critically ill patients, albeit just a few patients but their stock had largely increased to the news of assisting of a few patients...
There will be some time before recruitment, enrollment and we start to get data on efficacy but I'm here for the long haul...this looks like it'll be one of the largest PH 3 trials currently being conducted for early onset symptoms of COVID with 1000 participants...
Anyone else know what other studies of this size are currently in PH 3 taking a similar approach as us?
"In April, it applied to the US regulator to carry out a phase II trial in COVID-19 and was surprised by the response.
Based on Bucillamine’s composition, efficacy, safety and history, as well as a previous, successful interaction with the FDA, the drugs watchdog asked Revive to prepare an Investigational New Drug (IND) submission for a phase III confirmatory trial in COVID-19."
I think this could be a massive run though...$50 mil market cap and so many of these at earlier stages are trading well over $1 billion market cap
Shit even if we get to a $500 mil market cap still 1000% move coming
This is huge and so under the radar but so much big money I am talking to won't even touch it on OTC, let alone the Pink's
Company should use this opportunity to get current on their filings and get off the Pink's to OTCQB...I think that'll be coming as they try to attract bigger investments
Already past the "it's safe" part...that's why are in PH 3...PH 1 is used to check the safety profile of a drug, PH 3 is used to check it's efficacy
My guess is they don't have money to fund a PH 3, so many agencies been handing $$ out hand over fist for vaccines and other drugs...if this gets any kind of government or third party funding I'll see you all on the moon!
Lol I did the same and I bought 150k shares...too much promise here